The requirement for AP-1 activation for tumor promotion was subsequently shown using transgenic mice expressing the c-jun transactivation mutant TAM67, under the control of the basal cell specific keratin 14 promoter [12]. The gene discussed is JUNB; the disease is neoplasm.